Clinical Trials Logo

Pancreatic Cancers clinical trials

View clinical trials related to Pancreatic Cancers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03162510 Completed - Clinical trials for Gastric Cancer in Situ

Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

SOLAR
Start date: June 26, 2018
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to determine the maximal tolerated dose (MTD) of Oxaliplatin in this phase I study. The secondary objectives are to determine the response rate, progression free survival, overall survival, and safety profiles. Eligible patients will receive a triplet chemotherapy consisting of nab-paclitaxel (Abraxane®) 150 mg/m2 IVD 30 min followed by Oxaliplatin 60 - 85 mg/m2 IVD 2hr at D1, plus oral S-1 35mg/m2 and Leucovorin 30mg twice daily from D1 to D7, every 14 days as a cycle till disease progression.

NCT ID: NCT02374255 Completed - Colorectal Cancer Clinical Trials

Improving Goals of Care Discussion in Advanced Cancer Patients

Start date: March 15, 2016
Phase: N/A
Study type: Interventional

The goal of this study is to increase and improve Goals of Care discussions for advanced cancer patients by training medical oncologists to conduct these discussions. The investigators will evaluate the GoC discussion's effects on patient satisfaction, receipt of treatment in line with preferences, use of aggressive treatment, and oncologist communication skill.